The store will not work correctly when cookies are disabled.
JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.
JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.
很抱歉, 生成此内容时发生错误。
Copyright © 2025 by STEMCELL Technologies. All rights reserved.